Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Cambridge_Antibody_Technology> ?p ?o }
- Cambridge_Antibody_Technology wikiPageWikiLink Interleukin_23.
- Cambridge_Antibody_Technology wikiPageWikiLink Investigational_New_Drug.
- Cambridge_Antibody_Technology wikiPageWikiLink John_McCafferty.
- Cambridge_Antibody_Technology wikiPageWikiLink Kevin_Johnson_(venture_capitalist).
- Cambridge_Antibody_Technology wikiPageWikiLink Lerdelimumab.
- Cambridge_Antibody_Technology wikiPageWikiLink Lexatumumab.
- Cambridge_Antibody_Technology wikiPageWikiLink London_Stock_Exchange.
- Cambridge_Antibody_Technology wikiPageWikiLink Mapatumumab.
- Cambridge_Antibody_Technology wikiPageWikiLink Mavrilimumab.
- Cambridge_Antibody_Technology wikiPageWikiLink MedImmune.
- Cambridge_Antibody_Technology wikiPageWikiLink Medical_Research_Council_(United_Kingdom).
- Cambridge_Antibody_Technology wikiPageWikiLink Medicine.
- Cambridge_Antibody_Technology wikiPageWikiLink Melbourn_Science_Park.
- Cambridge_Antibody_Technology wikiPageWikiLink Mesothelin.
- Cambridge_Antibody_Technology wikiPageWikiLink Messenger_RNA.
- Cambridge_Antibody_Technology wikiPageWikiLink Metelimumab.
- Cambridge_Antibody_Technology wikiPageWikiLink Monoclonal_antibody.
- Cambridge_Antibody_Technology wikiPageWikiLink Monsanto.
- Cambridge_Antibody_Technology wikiPageWikiLink MorphoSys.
- Cambridge_Antibody_Technology wikiPageWikiLink Moxetumomab_pasudotox.
- Cambridge_Antibody_Technology wikiPageWikiLink NASDAQ.
- Cambridge_Antibody_Technology wikiPageWikiLink National_Cancer_Institute.
- Cambridge_Antibody_Technology wikiPageWikiLink National_Institutes_of_Health.
- Cambridge_Antibody_Technology wikiPageWikiLink Nature_(journal).
- Cambridge_Antibody_Technology wikiPageWikiLink Niels_Kaj_Jerne.
- Cambridge_Antibody_Technology wikiPageWikiLink Nobel_Prize.
- Cambridge_Antibody_Technology wikiPageWikiLink Nobel_Prize_in_Chemistry.
- Cambridge_Antibody_Technology wikiPageWikiLink Non-Hodgkin_lymphoma.
- Cambridge_Antibody_Technology wikiPageWikiLink Order_of_the_British_Empire.
- Cambridge_Antibody_Technology wikiPageWikiLink Ovarian_cancer.
- Cambridge_Antibody_Technology wikiPageWikiLink Pancreatic_cancer.
- Cambridge_Antibody_Technology wikiPageWikiLink Peritoneal_mesothelioma.
- Cambridge_Antibody_Technology wikiPageWikiLink Pfizer.
- Cambridge_Antibody_Technology wikiPageWikiLink Phage_display.
- Cambridge_Antibody_Technology wikiPageWikiLink Pharmaceutical_industry_in_the_United_Kingdom.
- Cambridge_Antibody_Technology wikiPageWikiLink Pharmacia.
- Cambridge_Antibody_Technology wikiPageWikiLink Physiology.
- Cambridge_Antibody_Technology wikiPageWikiLink Pleural_cavity.
- Cambridge_Antibody_Technology wikiPageWikiLink Polysome.
- Cambridge_Antibody_Technology wikiPageWikiLink Protein.
- Cambridge_Antibody_Technology wikiPageWikiLink Protein_microarray.
- Cambridge_Antibody_Technology wikiPageWikiLink Proteomics.
- Cambridge_Antibody_Technology wikiPageWikiLink Pseudomonas_exotoxin.
- Cambridge_Antibody_Technology wikiPageWikiLink Psoriasis.
- Cambridge_Antibody_Technology wikiPageWikiLink Public_limited_company.
- Cambridge_Antibody_Technology wikiPageWikiLink Raxibacumab.
- Cambridge_Antibody_Technology wikiPageWikiLink Ribosome_display.
- Cambridge_Antibody_Technology wikiPageWikiLink Rosalind_Franklin.
- Cambridge_Antibody_Technology wikiPageWikiLink Royalty_payment.
- Cambridge_Antibody_Technology wikiPageWikiLink Sanofi.
- Cambridge_Antibody_Technology wikiPageWikiLink Science_park.
- Cambridge_Antibody_Technology wikiPageWikiLink Scleroderma.
- Cambridge_Antibody_Technology wikiPageWikiLink Scripps_Research_Institute.
- Cambridge_Antibody_Technology wikiPageWikiLink Shareholder.
- Cambridge_Antibody_Technology wikiPageWikiLink Stop_codon.
- Cambridge_Antibody_Technology wikiPageWikiLink Systemic_lupus_erythematosus.
- Cambridge_Antibody_Technology wikiPageWikiLink TGF_beta_1.
- Cambridge_Antibody_Technology wikiPageWikiLink Tralokinumab.
- Cambridge_Antibody_Technology wikiPageWikiLink Tumor_necrosis_factor_alpha.
- Cambridge_Antibody_Technology wikiPageWikiLink Tumors_of_the_hematopoietic_and_lymphoid_tissues.
- Cambridge_Antibody_Technology wikiPageWikiLink UCB_(company).
- Cambridge_Antibody_Technology wikiPageWikiLink United_Kingdom.
- Cambridge_Antibody_Technology wikiPageWikiLink University_College_London.
- Cambridge_Antibody_Technology wikiPageWikiLink Wellcome_Trust_Sanger_Institute.
- Cambridge_Antibody_Technology wikiPageWikiLink File:Black_with_strap_v2.png.
- Cambridge_Antibody_Technology wikiPageWikiLinkText "CAT patent estate".
- Cambridge_Antibody_Technology wikiPageWikiLinkText "Cambridge Antibody Technology".
- Cambridge_Antibody_Technology wikiPageWikiLinkText "Oxford Glycosciences".
- Cambridge_Antibody_Technology areaServed "Worldwide".
- Cambridge_Antibody_Technology assets "12958.8".
- Cambridge_Antibody_Technology equity "10858.2".
- Cambridge_Antibody_Technology fate "Acquired by AstraZeneca in 2006; combined with MedImmune in 2007".
- Cambridge_Antibody_Technology footnotes "*Financials for six-month period prior to acquisition by AstraZeneca were distorted by the settlement for royalties payable on Adalimumab sales".
- Cambridge_Antibody_Technology foundation "1989".
- Cambridge_Antibody_Technology founder "David Chiswell, Sir Greg Winter, John McCafferty, Medical Research Council".
- Cambridge_Antibody_Technology industry "Biopharmaceutical".
- Cambridge_Antibody_Technology intl "Yes".
- Cambridge_Antibody_Technology keyPeople David_Chiswell.
- Cambridge_Antibody_Technology keyPeople "Peter Chambré".
- Cambridge_Antibody_Technology location Cambridgeshire.
- Cambridge_Antibody_Technology location England.
- Cambridge_Antibody_Technology location Granta_Park.
- Cambridge_Antibody_Technology location United_Kingdom.
- Cambridge_Antibody_Technology logo "200".
- Cambridge_Antibody_Technology name "Cambridge Antibody Technology Group Plc".
- Cambridge_Antibody_Technology netIncome "1515.0".
- Cambridge_Antibody_Technology numEmployees "Approximately 300".
- Cambridge_Antibody_Technology operatingIncome "8835.0".
- Cambridge_Antibody_Technology owner "AstraZeneca".
- Cambridge_Antibody_Technology products "Adalimumab, discovery of; belimumab discovery of".
- Cambridge_Antibody_Technology revenue "10350.0".
- Cambridge_Antibody_Technology services "Therapeutic monoclonal antibody discovery and development".
- Cambridge_Antibody_Technology successor MedImmune.
- Cambridge_Antibody_Technology type Public_limited_company.
- Cambridge_Antibody_Technology wikiPageUsesTemplate Template:AstraZeneca.
- Cambridge_Antibody_Technology wikiPageUsesTemplate Template:Cite_journal.
- Cambridge_Antibody_Technology wikiPageUsesTemplate Template:Convert.
- Cambridge_Antibody_Technology wikiPageUsesTemplate Template:End_date.
- Cambridge_Antibody_Technology wikiPageUsesTemplate Template:Infobox_company.
- Cambridge_Antibody_Technology wikiPageUsesTemplate Template:LSE.